cspc pharma limited submitted a new share change report on September 12, 2024, disclosing the latest repurchase situation of the company's shares. According to the report, cspc pharma repurchased and planned to cancel a total of 10,840,000 shares through the exchange of the Hong Kong Stock Exchange between August 23, 2024, and September 12, 2024, accounting for 0.091% of the issued shares. The average price range of the repurchased shares was between HKD 4.5456 and HKD 4.912. This share repurchase was carried out in accordance with the repurchase authorization passed at the shareholder meeting on May 28, 2024, and within 30 days after the repurchase, the company will not carry out any new share issuance or sale or transfer of treasury shares. This share repurchase action of cspc pharma is conducted in accordance with the relevant rules of the Hong Kong Stock Exchange.

cspc pharma limited submitted a new share change report on September 12, 2024, disclosing the latest repurchase situation of the company's shares. According to the report, cspc pharma repurchased and planned to cancel a total of 10,840,000 shares through the exchange of the Hong Kong Stock Exchange between August 23, 2024, and September 12, 2024, accounting for 0.091% of the issued shares. The average price range of the repurchased shares was between HKD 4.5456 and HKD 4.912. This share repurchase was carried out in accordance with the repurchase authorization passed at the shareholder meeting on May 28, 2024, and within 30 days after the repurchase, the company will not carry out any new share issuance or sale or transfer of treasury shares. This share repurchase action of cspc pharma is conducted in accordance with the relevant rules of the Hong Kong Stock Exchange.